Cashu | News | NVO

HomeWatchlistNewsSignalsPicks

DJI

+0.77%

SPX

+0.83%

IXIC

+0.98%

FTSE

+0.42%

N225

0.00%

AXJO

0.00%

HomeWatchlistNewsSignalsPicks

Stocks

0.00 (0.00%)

0.000

USD

At close at --,----

Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

About Us
Careers
Blog
News

Help & Support

Help Center
Contact Us
Pro Support

Legal

Privacy Policy
Terms of Use

Instagram YouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Latest Novo Nordisk News

Sanofi Hit With Shock As Flagship Drug Successor Disappoints Investors

Feature Image for interests on Biotech, Expert Ideas, Financial Services, Healthcare from benzinga.com

about 10 hours ago

Healthy Returns: Novo Nordisk’s head of research and development previews the first-ever obesity pill

Feature Image for interests on Biotech And Pharmaceuticals, Health Care Industry, Healthcare, Social Issues from cnbc.com

After Copycat Boom, China's Drugmakers Target Global Generics

Feature Image for interests on Biotech, China, Consumer Defensive, Expert Ideas from benzinga.com

Cytokinetics (CYTK) Stock Is Skyrocketing Tuesday: What's Driving The Action?

Feature Image for interests on Healthcare, News, Stock, Unknown Sector from benzinga.com

Novo Nordisk's Wegovy Outshines Eli Lilly's Tirzepatide In Reducing Risk Of Heart Attack Stroke And Death

Feature Image for interests on Biotech, Health Care, Healthcare, Large Cap from benzinga.com

Wegovy heart risk trial gives boost to Novo Nordisk amid U.S. market woes

Feature Image for interests on Breaking News: Markets, Healthcare, Markets, Pharmaceuticals from cnbc.com

Novo Nordisk's Wegovy cuts risk of heart attack, stroke or death by 57% compared to tirzepatide in real-world study of people with obesity and cardiovascular disease

Feature Image for interests on Clinical Trials & Medical Discoveries, Health Care & Hospitals, Healthcare, Medical Pharmaceuticals from prnewswire.com

Eli Lilly Is Proof That Wall Street Stars Don't Have To Be Tech Titans

Novo Nordisk Slowdown Weighs On Denmark's Economic Outlook

Feature Image for interests on Biotech, Denmark, Expert Ideas, Healthcare from benzinga.com

Teva Launches Generic GLP-1 Weight Loss Drug With FDA Nod For Saxenda

Feature Image for interests on Biotech, Healthcare, Large Cap, News from benzinga.com

Stocks

Health Care

nvo

Novo Nordisk

OMX NORDIC EXCHANGE COPENHAGEN A/S: NVO

-0.67 (-1.18%)

56.07

USD

At close at Sep 04, 20:37 UTC

Latest Cashu News

Novo Nordisk Enhances Cardiovascular Care with Patient-Centric Findings from STEER Study

about 4 hours ago

Wegovy's Heart Health Benefits Position Novo Nordisk as Leader in Weight Management Market

Wegovy® by Novo Nordisk: Cardiovascular Risk Reduction in Obese Patients at ESC Congress 2025